[{"address1": "1375 West Fulton Street", "address2": "Suite 1300", "city": "Chicago", "state": "IL", "zip": "60607", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1065572, "exercisedValue": 0, "unexercisedValue": 341267}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "age": 60, "title": "President & COO", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 777048, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 747017, "exercisedValue": 30004, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 767825, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 2597639, "exercisedValue": 0, "unexercisedValue": 1357712}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anh  Nguyen M.B.A., M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 5.04, "open": 5.01, "dayLow": 4.89, "dayHigh": 5.0847, "regularMarketPreviousClose": 5.04, "regularMarketOpen": 5.01, "regularMarketDayLow": 4.89, "regularMarketDayHigh": 5.0847, "payoutRatio": 0.0, "beta": 0.913, "forwardPE": -22.454546, "volume": 2371184, "regularMarketVolume": 2257127, "averageVolume": 3141020, "averageVolume10days": 1791040, "averageDailyVolume10Day": 1791040, "bid": 4.9, "ask": 4.98, "bidSize": 3, "askSize": 3, "marketCap": 791165760, "fiftyTwoWeekLow": 2.03, "fiftyTwoWeekHigh": 6.07, "priceToSalesTrailing12Months": 3.5549862, "fiftyDayAverage": 4.7592, "twoHundredDayAverage": 3.6745, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1001476672, "profitMargins": -0.20254, "floatShares": 153926572, "sharesOutstanding": 160155008, "sharesShort": 17803095, "sharesShortPriorMonth": 19050282, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.1112, "heldPercentInsiders": 0.04, "heldPercentInstitutions": 0.54337, "shortRatio": 7.8, "shortPercentOfFloat": 0.1157, "impliedSharesOutstanding": 163728000, "bookValue": -0.225, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -45076000, "trailingEps": -0.29, "forwardEps": -0.22, "enterpriseToRevenue": 4.5, "enterpriseToEbitda": -231.128, "52WeekChange": 1.0163264, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 4.94, "targetHighPrice": 7.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.1, "targetMedianPrice": 6.5, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 58440000, "totalCashPerShare": 0.365, "ebitda": -4333000, "totalDebt": 268751008, "quickRatio": 1.102, "currentRatio": 1.72, "totalRevenue": 222551008, "revenuePerShare": 1.486, "returnOnAssets": -0.03142, "grossProfits": 182962000, "freeCashflow": -5904125, "operatingCashflow": -26709000, "revenueGrowth": 0.479, "grossMargins": 0.82211, "ebitdaMargins": -0.01947, "operatingMargins": -0.0514, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Xeris Biopharma Holdings, Inc.", "longName": "Xeris Biopharma Holdings, Inc.", "corporateActions": [], "postMarketTime": 1748640926, "regularMarketTime": 1748635201, "exchange": "NMS", "messageBoardId": "finmb_105901792", "market": "us_market", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "regularMarketChangePercent": -1.98413, "regularMarketPrice": 4.94, "fiftyTwoWeekChangePercent": 101.632645, "earningsTimestamp": 1746702000, "earningsTimestampStart": 1754566200, "earningsTimestampEnd": 1754566200, "earningsCallTimestampStart": 1746707400, "earningsCallTimestampEnd": 1746707400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.29, "epsForward": -0.22, "epsCurrentYear": -0.09, "priceEpsCurrentYear": -54.888885, "fiftyDayAverageChange": 0.18079996, "fiftyDayAverageChangePercent": 0.037989568, "twoHundredDayAverageChange": 1.2655001, "twoHundredDayAverageChangePercent": 0.3444006, "priceToBook": -21.955557, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2025-05-29", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": 0.202424, "postMarketPrice": 4.95, "postMarketChange": 0.00999975, "regularMarketChange": -0.0999999, "regularMarketDayRange": "4.89 - 5.0847", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3141020, "fiftyTwoWeekLowChange": 2.91, "fiftyTwoWeekLowChangePercent": 1.4334975, "fiftyTwoWeekRange": "2.03 - 6.07", "fiftyTwoWeekHighChange": -1.1300001, "fiftyTwoWeekHighChangePercent": -0.18616146, "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]